- Recommendation ID
- NG136/05
- Question
Relaxation therapies: What is the clinical and cost effectiveness of relaxation therapies for managing primary hypertension in adults in terms of reducing cardiovascular events and improving quality of life?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale on relaxation therapies.
Full details of the evidence and the committee's discussion are in evidence review H: relaxation therapies.
Source guidance details
- Comes from guidance
- Hypertension in adults: diagnosis and management
- Number
- NG136
- Date issued
- August 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/03/2022 |